Proven leaders and clinicians focused on your safe, efficient operation every day.
Abbas Khan is Managing Partner and Co-Founder at Bloom Health Partners. A true collaborator with a knack for building teams and implementing creative solutions, Abbas embodies Bloom Health Partner’s mission to ensure “unstoppable is possible.” His entrepreneurial spirit and strategic thinking have been instrumental in forming key partnerships to grow Bloom’s client base in the U.S. and expand its best-in-class clinical operations to other countries.
Prior to working with Bloom, Abbas served as Business Development and Marketing Manager for Life Biosciences and Commercialization Director for the cutting-edge health tech company CloudMex, where he led the rebrand of their communication strategy and managed their partnership and product development with Anthem Health. His background also includes strategic marketing roles at Sterling-Rice Group and PepsiCo. Abbas is currently pursuing his MBA in Healthcare at the Yale School of Management.
Outside of work, Abbas enjoys time with his family and supporting charitable causes with his wife and through their family’s foundation, which was founded by his philanthropist mother and father. The Khan Family Foundation actively focuses its charitable giving on underserved youth, education initiatives and women’s empowerment.
Cole Lysaught is Managing Partner and Co-Founder at Bloom Health Partners. An entrepreneur at heart, Cole brings with him a strong background in financial and operational leadership. He has an extensive track record with investing and scaling new and existing portfolio companies, investment management, building teams and guiding operations.
Prior to working at Bloom, Cole was a Partner at Ahkeo Ventures, an early-stage Venture Capital Firm. Since 2011, he has facilitated over $1 billion USD in transactions across a wide range of industries, including: energy, banking, hospitality and tourism. Cole continues to build value as a leader and investor at CPL investments, an investment management firm where he also currently serves as Managing Partner.
Cole serves as a US Delegate to the G 20 Entrepreneurial Summits in Toronto and Mexico City, and he serves on the Dallas Alumni Board of Directors at Texas Christian University. Previously, he spent six years as a Host Committee Member for the Great Investors’ Best Ideas Foundation (GIBI, a nonprofit organization that benefits The Michael J. Fox Foundation for Parkinson’s Research and the Vickery Meadow Youth Development Foundation. He graduated cum laude from Texas Christian University with a BBA in Finance and Entrepreneurial Management.
Mike Medina, M.P.A, M.H.A., is Chief Operations Officer at Bloom Health Partners. A dynamic leader with a passion for healthcare operations, Mike is committed to charting the course for the future of Bloom Health Partners. Mike has served as the Associate Vice President of Clinical Ancillary Services at University of Texas Southwestern Medical Center. Mike brings more than 40 years of experience to the Bloom Health Partners team. Prior to his current role, Mike served as Commander U.S. Navy Retired in the Medical Service Corps and was part of the Johns Hopkins International Relations team. He’s also worked with the Cleveland Clinic and the National Institute of Health.
Mike is passionate about sharing his knowledge and lending counsel to fellow peers and students. He currently serves as an Advisory Board Member for Ithaca College Advisory Board and served as the Executive Sponsor for the University of Texas Southwestern Administrative Fellowship Program. He’s also a member of the Medical Group Management Association, American College of Healthcare Executives and the Navy League.
With diverse experience in pharmaceutical, clinical and consumer industries, Mehmood Khan, M.D. brings a wealth of knowledge to his role as Senior Health Advisor at Bloom Health Partners. Currently the Chairman and Chief Executive Officer of Life Biosciences Inc., he provides strategic direction and operational oversight across Life Biosciences and its six daughter companies. His vision of a more efficient and effective drug development pathway will drive innovation in the science and technology that Life Biosciences advances.
Dr. Khan previously served as Chief Scientific Officer and Vice Chairman at PepsiCo, a Fortune 500 company. Prior to joining PepsiCo, Dr. Khan served as President of Takeda Pharmaceuticals, leading the global efforts of one of the largest pharmaceutical companies in the world by revenue. Earlier in his career, Dr. Khan had a distinguished medical career as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit.
Dr. Khan is the recipient of numerous distinctions and awards, including The Harris Award for Excellence in Food and Science Technology, a Harvard University Illuminate Global Award for Innovation and was named one of the 100 Most Creative People in Business by Fast Company. Dr. Khan has also held leadership roles on numerous boards and currently serves as Chairman of the U.S. Council on Competitiveness, as a V-Cat Board Member and as a NIST Board Member.
Dr. Khan earned his medical degree from the University of Liverpool Medical School, England and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis. He is a Fellow of the Royal College of Physicians, London, and a Fellow of the American College of Endocrinology.
Board Certified in Internal Medicine and Infectious Disease, Alexander Stemer, M.D. welcomes the challenge of solving new problems and has been instrumental in the fight against COVID-19, developing infection control programs and protocols for hospitals and skilled nursing facilities.
In addition to serving as Associate Clinical Professor of Medicine at the Indiana University School of Medicine, Dr. Stemer currently serves as the co-chair of the Symphony Health Network COVID-19 Task Force. He also recently worked with the National Institute of Health and Eli Lilly to develop study protocols for prevention and treatment of COVID-19 in skilled nursing facilities using monoclonal antibody. The study was approved by the FDA, completed and recently published in the Journal of the American Medical Association.
Dr. Stemer brings more than 42 years of experience to the Bloom Health Partners team and was recently named the American Heart Association Heart of Gold Executive Chairman for 2022.
Honorable, Eric D. Hargan, JD, is the Senior Health Advisor for Bloom Health Partners. He was a Former Deputy Secretary of the United States Department of Health and Human Services. As Deputy Secretary of HHS, the largest department in the federal government, he oversaw the development and approval of all HHS, CMS, and FDA regulations and significant guidances as well as the department’s day-to-day operations and management, and he led policy and strategy development.
Eric served on the board of Operation Warp Speed, where he signed the first document that enabled the start of Operation Warp Speed. This was a public–private partnership initiated by the U.S. government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.
He also was a Board Member at University Hospitals and Alio Medical, and is a Fellow at the Health Evolution Forum.
Leah Shaffer, Ph.D. is the Director of Science for Bloom Health Partners. Leah has a Ph. D. in analytical chemistry from the University of Idaho where she specialized in analytical instrumentation and testing methodology. As Scientific Director, she designs customized analytical platforms for workforce wellness programs.
Working at Bloom Health Partners has been such a great experience because of the incredible knowledge of the entire team. Being able to help the world out in such a scary time, it is just such a fulfilling job. This company goes above and beyond to ensure the safety of the public, with such expertise in an ever changing environment. I couldn't be more proud of the company I work for and the team that I am surrounded by.